1-[4-(4-Phenylbutoxy)phenyl]ethanone | 62874-69-5

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 1-[4-(4-Phenylbutoxy)phenyl]ethanone
• CAS: 62874-69-5
• 化学式: C₁₈H₂₀O₂
• 分子量: 268.356
• InChiKey: ARDGPHDJSMMLPG-UHFFFAOYSA-N

物化性质

• 沸点：
  424.3±28.0 °C(Predicted)
• 密度：
  1.051±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  20
• 可旋转键数：
  7
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.28
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-[4-(4-Phenylbutoxy)phenyl]ethanone 在 copper(ll) bromide 作用下， 以 氯仿 、 乙酸乙酯 为溶剂， 生成 2-bromo-1-[4-(4-phenyl-butoxy)phenyl]-ethanone
  参考文献：
  名称：

  Synthesis and evaluation of arylalkoxy- and biarylalkoxy-phenylamide and phenylimidazoles as potent and selective sphingosine-1-phosphate receptor subtype-1 agonists

  摘要：

  In pursuit of potent and selective sphingosine-1-phosphate receptor agonists, we have utilized previously reported phenylamide and phenylimidazole scaffolds to explore extensive side-chain modi. cations to generate new molecular entities. A number of designed molecules demonstrate good selectivity and excellent in vitro and in vivo potency in both mouse and rat models. Oral administration of the lead molecule 11c (PPI-4667) demonstrated potent and dose-responsive lymphopenia. (c) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2009.02.073
• 作为产物：
  描述：

  4-苯基丁醇 、 4-氟苯乙酮 在 potassium tert-butylate 作用下， 以 四氢呋喃 为溶剂， 生成 1-[4-(4-Phenylbutoxy)phenyl]ethanone
  参考文献：
  名称：

  Synthesis and evaluation of arylalkoxy- and biarylalkoxy-phenylamide and phenylimidazoles as potent and selective sphingosine-1-phosphate receptor subtype-1 agonists

  摘要：

  In pursuit of potent and selective sphingosine-1-phosphate receptor agonists, we have utilized previously reported phenylamide and phenylimidazole scaffolds to explore extensive side-chain modi. cations to generate new molecular entities. A number of designed molecules demonstrate good selectivity and excellent in vitro and in vivo potency in both mouse and rat models. Oral administration of the lead molecule 11c (PPI-4667) demonstrated potent and dose-responsive lymphopenia. (c) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2009.02.073

文献信息

• 一种合成烷基芳基醚的方法
  申请人：中国人民解放军空军军医大学

  公开号：CN117586106A

  公开（公告）日：2024-02-23

  本发明公开了一种简便合成烷基芳基醚的方法。该方法以廉价且来源丰富的芳基或杂芳基卤化物和醇作为底物，在还原剂、有机碱存在下，成功实现廉价过渡金属镍催化的碳氧键偶联反应，温和条件下高产率制备系列烷基芳基醚类化合物。本发明所述原料简单易得，反应过程操作简单、条件温和，且收率高、底物范围广，避免了传统的贵金属催化剂以及无机碱的使用造成催化体系反应复杂、官能团兼容性差等问题，是一种简单、高效合成烷基芳基醚的方法，具有较好的应用前景。
• CONDENSED RING COMPOUND AND USE THEREOF
  申请人：ONO PHARMACEUTICAL CO., LTD.

  公开号：EP1661892B1

  公开（公告）日：2013-07-24
• US4038412A
  申请人：——

  公开号：US4038412A

  公开（公告）日：1977-07-26
• Synthesis and evaluation of arylalkoxy- and biarylalkoxy-phenylamide and phenylimidazoles as potent and selective sphingosine-1-phosphate receptor subtype-1 agonists
  作者：Ghotas Evindar、Alexander L. Satz、Sylvie G. Bernier、Malcolm J. Kavarana、Elisabeth Doyle、Jeanine Lorusso、Nazbeh Taghizadeh、Keith Halley、Amy Hutchings、Michael S. Kelley、Albion D. Wright、Ashis K. Saha、Gerhard Hannig、Barry A. Morgan、William F. Westlin

  DOI：10.1016/j.bmcl.2009.02.073

  日期：2009.4

  In pursuit of potent and selective sphingosine-1-phosphate receptor agonists, we have utilized previously reported phenylamide and phenylimidazole scaffolds to explore extensive side-chain modi. cations to generate new molecular entities. A number of designed molecules demonstrate good selectivity and excellent in vitro and in vivo potency in both mouse and rat models. Oral administration of the lead molecule 11c (PPI-4667) demonstrated potent and dose-responsive lymphopenia. (c) 2009 Elsevier Ltd. All rights reserved.